VETO logo

Vetoquinol SA Stock Price

ENXTPA:VETO Community·€852.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

VETO Share Price Performance

€72.30
-7.00 (-8.83%)
€72.30
-7.00 (-8.83%)
Price €72.30

VETO Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Undervalued with solid track record.

0 Risks
4 Rewards

Vetoquinol SA Key Details

€532.4m

Revenue

€224.2m

Cost of Revenue

€308.2m

Gross Profit

€248.3m

Other Expenses

€60.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
5.08
57.89%
11.26%
0.5%
View Full Analysis

About VETO

Founded
1933
Employees
2497
CEO
Matthieu Frechin
WebsiteView website
www.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Recent VETO News & Updates

Recent updates

No updates